University of Cambridge
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private
- Established
- 1209-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.cam.ac.uk
Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)
- First Posted Date
- 2006-11-02
- Last Posted Date
- 2011-10-25
- Lead Sponsor
- University of Cambridge
- Target Recruit Count
- 10
- Registration Number
- NCT00395200
- Locations
- π¬π§
University College London Institute of Neurology, London, United Kingdom
π¬π§University of Cambridge Dept of Clinical Neurosciences, Cambridge, Cambridgeshire, United Kingdom
Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension
Not Applicable
- Conditions
- First Posted Date
- 2006-09-25
- Last Posted Date
- 2006-09-25
- Lead Sponsor
- University of Cambridge
- Target Recruit Count
- 66
- Registration Number
- NCT00380289
- Locations
- π¬π§
Clinical Pharmacology Unit, Box 110, Level 3 ACCI, Addenbrookes Hospital, Cambridge, United Kingdom
Healthy Volunteer Study of Sildenafil Effects Upon Vision
Phase 4
Completed
- Conditions
- First Posted Date
- 2005-11-10
- Last Posted Date
- 2005-11-10
- Lead Sponsor
- University of Cambridge
- Registration Number
- NCT00251784
Primary Thrombocythaemia 1 Trial
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- University of Cambridge
- Target Recruit Count
- 1398
- Registration Number
- NCT00175838
- Locations
- π¬π§
Addenbrooke's Hospital, Cambridge, Cambs, United Kingdom
Erythropoietin Therapy for Subarachnoid Hemorrhage
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2009-05-20
- Lead Sponsor
- University of Cambridge
- Target Recruit Count
- 80
- Registration Number
- NCT00140010
- Locations
- π¬π§
Department of Neurosurgery, Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom
Β© Copyright 2024. All Rights Reserved by MedPath